ResearcherPhilipps University of MarburgActive in the last 2 years
Martin Eilers
Matched on ORCID iD 0000-0002-0376-6533; OpenAlex author ID A5043955969. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 44
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 6
- MYC/MIZ1 suppression of lysosomal protein degradation drives immune evasion in pancreatic ductal adenocarcinoma Last author DOI 10.64898/2026.07.23.740267↗
- Pharmacological arginine deprivation renders pancreatic cancer cells susceptible to senolysis and inhibition of the integrated stress response Co-author DOI 10.64898/2026.08.03.740778↗
- Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. Co-author DOI 10.1136/gutjnl-2023-331519↗
- New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting. Co-author DOI 10.1053/j.gastro.2021.04.082↗
- MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1158/0008-5472.can-21-1677↗
- Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. Co-author DOI 10.1158/2159-8290.cd-13-0593↗
Closest collaborators
The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elmar Wolf · 4 shared papers, 2014–2026 · strength 0.54
- Paper Pharmacological arginine deprivation renders pancreatic cancer cells susceptible to senolysis and inhibition of the int… DOI 10.64898/2026.08.03.740778↗
- Paper Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. DOI 10.1136/gutjnl-2023-331519↗
- Paper MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarc… DOI 10.1158/0008-5472.can-21-1677↗
- Mathias Tillmann Rosenfeldt · 3 shared papers, 2021–2026 · strength 0.51
- Paper Pharmacological arginine deprivation renders pancreatic cancer cells susceptible to senolysis and inhibition of the int… DOI 10.64898/2026.08.03.740778↗
- Paper Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. DOI 10.1136/gutjnl-2023-331519↗
- Paper MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarc… DOI 10.1158/0008-5472.can-21-1677↗
- Dieter Saur · 3 shared papers, 2021–2026 · strength 0.46
- Paper MYC/MIZ1 suppression of lysosomal protein degradation drives immune evasion in pancreatic ductal adenocarcinoma DOI 10.64898/2026.07.23.740267↗
- Paper Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2. DOI 10.1136/gutjnl-2023-331519↗
- Paper New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting. DOI 10.1053/j.gastro.2021.04.082↗
- Bastian Krenz · 3 shared papers, 2021–2026 · strength 0.41
- Paper MYC/MIZ1 suppression of lysosomal protein degradation drives immune evasion in pancreatic ductal adenocarcinoma DOI 10.64898/2026.07.23.740267↗
- Paper MYC- and MIZ1-Dependent Vesicular Transport of Double-Strand RNA Controls Immune Evasion in Pancreatic Ductal Adenocarc… DOI 10.1158/0008-5472.can-21-1677↗
- Paper New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting. DOI 10.1053/j.gastro.2021.04.082↗
- Jennifer P. Morton · 2 shared papers, 2021–2026 · strength 0.33
- Laura Mainz · 1 shared paper, 2026 · strength 0.24
- Almut Schulze · 1 shared paper, 2026 · strength 0.24
- Markus Vogt · 1 shared paper, 2024 · strength 0.16
- Shiv K. Singh · 2 shared papers, 2014–2021 · strength 0.12
- Jens Thomas Siveke · 2 shared papers, 2014–2021 · strength 0.12
- Elisabeth Heßmann · 2 shared papers, 2014–2021 · strength 0.12
- Thomas Mathias Gress · 2 shared papers, 2014–2021 · strength 0.12
- Volker Ellenrieder · 2 shared papers, 2014–2021 · strength 0.12
- Karin Feldmann · 1 shared paper, 2021 · strength 0.09
- Stephan B. Dreyer · 1 shared paper, 2021 · strength 0.09
- Felix S.R. Picard · 1 shared paper, 2021 · strength 0.09
- Chiara Falcomatà · 1 shared paper, 2021 · strength 0.09
- Elisa Espinet · 1 shared paper, 2021 · strength 0.09
- Corinne Bousquet · 1 shared paper, 2021 · strength 0.09
- Magdalena Huber · 1 shared paper, 2021 · strength 0.09
- Andreas Trumpp · 1 shared paper, 2021 · strength 0.09
- Maximilian Reichert · 1 shared paper, 2021 · strength 0.09
- Steven A. Johnsen · 1 shared paper, 2021 · strength 0.09
- Feda H. Hamdan · 1 shared paper, 2021 · strength 0.09
- Roland Michael Schmid · 1 shared paper, 2021 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.